Nanmo Biology (688265.SH) has issued a profit warning, forecasting a parent net profit of 8 million to 10 million yuan for the first half of the year, a year-on-year decline of 44.96% to 55.97%.

Zhitong Finance APP News, Nanmo Biotechnology (688265.SH) released its performance forecast for the first half of 2026. The company expects to achieve a net profit attributable to the parent company of between 8 million and 10 million yuan, representing a year-on-year decline of 44.96% to 55.97%. It is also expected that after excluding the impact of share-based payments, the net profit attributable to the parent company will be between 13 million and 15.8 million yuan, a year-on-year increase of 47.27% to 78.99%.